Page last updated: 2024-08-18

4-butyrolactone and n-methyl-3,4-methylenedioxyamphetamine

4-butyrolactone has been researched along with n-methyl-3,4-methylenedioxyamphetamine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Colado, MI; Green, AR1
Goss, J1
Cuddy, ML1

Reviews

1 review(s) available for 4-butyrolactone and n-methyl-3,4-methylenedioxyamphetamine

ArticleYear
Common drugs of abuse--Part II.
    The Journal of practical nursing, 2004,Spring, Volume: 54, Issue:1

    Topics: 4-Butyrolactone; Catha; Designer Drugs; Dibenzothiazepines; Diterpenes; Diterpenes, Clerodane; DOM 2,5-Dimethoxy-4-Methylamphetamine; Drug and Narcotic Control; Flunitrazepam; Hallucinogens; Humans; Illicit Drugs; Ketamine; Lysergic Acid Diethylamide; Methamphetamine; Motivation; N-Methyl-3,4-methylenedioxyamphetamine; Phencyclidine; Phenylpropanolamine; Piperazines; Psilocybin; Quetiapine Fumarate; Sodium Oxybate; Substance-Related Disorders; United States

2004

Other Studies

2 other study(ies) available for 4-butyrolactone and n-methyl-3,4-methylenedioxyamphetamine

ArticleYear
A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds.
    British journal of pharmacology, 1994, Volume: 111, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; 3,4-Methylenedioxyamphetamine; 4-Butyrolactone; Animals; Brain; Chlormethiazole; Designer Drugs; Dizocilpine Maleate; Dopamine; Hydroxyindoleacetic Acid; Male; N-Methyl-3,4-methylenedioxyamphetamine; Ondansetron; Pentobarbital; Rats; Serotonin

1994
Designer drugs. Assess & manage patients intoxicated with ecstasy, GHB or rohypnol--the three most commonly abused designer drugs.
    JEMS : a journal of emergency medical services, 2001, Volume: 26, Issue:6

    Topics: 4-Butyrolactone; Designer Drugs; Education, Continuing; Emergency Medical Services; Emergency Treatment; Flunitrazepam; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Physical Examination; Substance-Related Disorders; United States

2001